Education
About Us
Working with TipRanks
Follow Us
Prestige Consumer Healthcare (PBH)
NYSE:PBH
Total Valuation
Prestige Consumer Healthcare has a market cap or net worth of $3.13B. The enterprise value is $4.88B.
Market Cap$3.13B
Enterprise Value$4.88B
Share Statistics
Prestige Consumer Healthcare has 49,214,172 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding49,214,172
Owned by Insiders1.29%
Owned by Institutions23.42%
Financial Efficiency
Prestige Consumer Healthcare’s return on equity (ROE) is 0.12 and return on invested capital (ROIC) is 7.70%.
Return on Equity (ROE)0.12
Return on Assets (ROA)0.06
Return on Invested Capital (ROIC)7.70%
Return on Capital Employed (ROCE)0.10
Revenue Per Employee1.90M
Profits Per Employee357.68K
Employee Count600
Asset Turnover0.33
Inventory Turnover3.41
Valuation Ratios
The current PE Ratio of Prestige Consumer Healthcare is 14.8. Prestige Consumer Healthcare’s PEG ratio is ―.
PE Ratio14.8
PS Ratio―
PB Ratio―
Price to Fair Value2.33
Price to FCF―
Price to Operating Cash Flow11.92
PEG Ratio―
Income Statement
In the last 12 months, Prestige Consumer Healthcare had revenue of 1.14B and earned 214.60M in profits. Earnings per share was 4.32.
Revenue1.14B
Gross Profit634.46M
Operating Income336.77M
Pretax Income284.19M
Net Income214.60M
EBITDA361.99M
Earnings Per Share (EPS)4.32
Cash Flow
In the last 12 months, operating cash flow was 275.75M and capital expenditures -7.91M, giving a free cash flow of 267.84M billion.
Operating Cash Flow275.75M
Free Cash Flow267.84M
Free Cash Flow per Share5.44
Dividends & Yields
Prestige Consumer Healthcare pays an annual dividend of $0.475, resulting in a dividend yield of ―
Dividend Per Share$0.475
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.28
52-Week Price Change-11.35%
50-Day Moving Average68.45
200-Day Moving Average78.84
Relative Strength Index (RSI)37.31
Average Volume (3m)618.73K
Important Dates
Prestige Consumer Healthcare upcoming earnings date is Oct 30, 2025, Before Open (Confirmed).
Last Earnings DateAug 7, 2025
Next Earnings DateOct 30, 2025
Ex-Dividend DateSep 27, 2018
Financial Position
Prestige Consumer Healthcare as a current ratio of 4.20, with Debt / Equity ratio of 56.20%
Current Ratio4.20
Quick Ratio2.82
Debt to Market Cap0.23
Net Debt to EBITDA2.61
Interest Coverage Ratio7.07
Taxes
In the past 12 months, Prestige Consumer Healthcare has paid 69.58M in taxes.
Income Tax69.58M
Effective Tax Rate0.24
Enterprise Valuation
Prestige Consumer Healthcare EV to EBITDA ratio is 14.42, with an EV/FCF ratio of 21.45.
EV to Sales4.59
EV to EBITDA14.42
EV to Free Cash Flow21.45
EV to Operating Cash Flow20.75
Balance Sheet
Prestige Consumer Healthcare has $139.50M in cash and marketable securities with $1.04B in debt, giving a net cash position of -$903.22M billion.
Cash & Marketable Securities$139.50M
Total Debt$1.04B
Net Cash-$903.22M
Net Cash Per Share-$18.35
Tangible Book Value Per Share-$19.88
Margins
Gross margin is 56.18%, with operating margin of 29.60%, and net profit margin of 18.86%.
Gross Margin56.18%
Operating Margin29.60%
Pretax Margin24.98%
Net Profit Margin18.86%
EBITDA Margin31.82%
EBIT Margin29.16%
Analyst Forecast
The average price target for Prestige Consumer Healthcare is $83.33, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$83.33
Price Target Upside31.75% Upside
Analyst ConsensusStrong Buy
Analyst Count4
Revenue Growth Forecast0.63%
EPS Growth Forecast4.23%